Atrium Innovations has introduced ChroNOline, a biomemitic tetrapeptide derived from a growth factor.
ChroNOline provides outstanding reduction of the appearance of fine lines and wrinkles after only 28 days, states Atrium Innovations.
Atrium Innovations has introduced ChroNOline, a biomemitic tetrapeptide derived from a growth factor.
Our company was established in 1958 as SEIWA KASEI Industry CO., LTD., an organization for the development of industrial decomposition technology of waxes and high melting point esters such as Beeswax, Privet wax, and Carnauba wax, and for the production of various types of emulsifying waxes. In 1966, we launched our products, hydrolyzed...
COEX, Seoul
2nd - 4th July 2025
Royal College of Surgeons of England, London
2 - 3 July